Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
VMF
0
Australia
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cubicin
2. Daptomycin, 9 L Beta Aspartic Acid
3. Daptomycin, 9-l Beta-aspartic Acid
4. Deptomycin
5. Ly 146032
6. Ly-146032
7. Ly146032
1. 103060-53-3
2. Cubicin
3. Deptomycin
4. Cidecin
5. Daptomycine [french]
6. Daptomycinum [latin]
7. Daptomicina [spanish]
8. Schembl1650768
9. Akos026750170
Molecular Weight | 1620.7 g/mol |
---|---|
Molecular Formula | C72H101N17O26 |
XLogP3 | -5.1 |
Hydrogen Bond Donor Count | 22 |
Hydrogen Bond Acceptor Count | 28 |
Rotatable Bond Count | 35 |
Exact Mass | 1619.71036639 g/mol |
Monoisotopic Mass | 1619.71036639 g/mol |
Topological Polar Surface Area | 702 Ų |
Heavy Atom Count | 115 |
Formal Charge | 0 |
Complexity | 3480 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 3 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 4 | |
---|---|
Drug Name | Cubicin |
PubMed Health | Daptomycin (Injection) |
Drug Classes | Antibiotic |
Drug Label | CUBICIN contains daptomycin, a cyclic lipopeptide antibacterial agent derived from the fermentation of Streptomyces roseosporus. The chemical name is N-decanoyl-L-tryptophyl-D-asparaginyl-L-aspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L... |
Active Ingredient | Daptomycin |
Dosage Form | Injectable |
Route | Iv (infusion) |
Strength | 500mg/vial |
Market Status | Prescription |
Company | Cubist |
2 of 4 | |
---|---|
Drug Name | Daptomycin |
PubMed Health | Daptomycin (Injection) |
Drug Classes | Antibiotic |
Drug Label | CUBICIN contains daptomycin, a cyclic lipopeptide antibacterial agent derived from the fermentation of Streptomyces roseosporus. The chemical name is N-decanoyl-L-tryptophyl-D-asparaginyl-L-aspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L... |
Active Ingredient | Daptomycin |
Dosage Form | Injectable |
Route | injection; Iv (infusion) |
Strength | 500mg/vial; 350mg |
Market Status | Tentative Approval; Prescription |
Company | Hospira |
3 of 4 | |
---|---|
Drug Name | Cubicin |
PubMed Health | Daptomycin (Injection) |
Drug Classes | Antibiotic |
Drug Label | CUBICIN contains daptomycin, a cyclic lipopeptide antibacterial agent derived from the fermentation of Streptomyces roseosporus. The chemical name is N-decanoyl-L-tryptophyl-D-asparaginyl-L-aspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L... |
Active Ingredient | Daptomycin |
Dosage Form | Injectable |
Route | Iv (infusion) |
Strength | 500mg/vial |
Market Status | Prescription |
Company | Cubist |
4 of 4 | |
---|---|
Drug Name | Daptomycin |
PubMed Health | Daptomycin (Injection) |
Drug Classes | Antibiotic |
Drug Label | CUBICIN contains daptomycin, a cyclic lipopeptide antibacterial agent derived from the fermentation of Streptomyces roseosporus. The chemical name is N-decanoyl-L-tryptophyl-D-asparaginyl-L-aspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L... |
Active Ingredient | Daptomycin |
Dosage Form | Injectable |
Route | injection; Iv (infusion) |
Strength | 500mg/vial; 350mg |
Market Status | Tentative Approval; Prescription |
Company | Hospira |
Cubicin is indicated for the treatment of the following infections.
- Adult and paediatric (1 to 17 years of age) patients with complicated skin and soft-tissue infections (cSSTI).
- Adult patients with right-sided infective endocarditis (RIE) due to Staphylococcus aureus.
It is recommended that the decision to use daptomycin should take into account the antibacterial susceptibility of the organism and should be based on expert advice.
- Adult and paediatric (1 to 17 years of age) patients with Staphylococcus aureus bacteraemia (SAB). In adults, use in bacteraemia should be associated with RIE or with cSSTI, while in paediatric patients, use in bacteraemia should be associated with cSSTI.
Daptomycin is active against Gram positive bacteria only. In mixed infections where Gram negative and/or certain types of anaerobic bacteria are suspected, Cubicin should be co-administered with appropriate antibacterial agent(s). Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J01XX09
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01X - Other antibacterials
J01XX - Other antibacterials
J01XX09 - Daptomycin
Comhony Biotech manufactures fermentation & semi-synthetic APIs which aim at dermatology, anti-biotics; mitochondria & memory health.
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-07-11
Pay. Date : 2013-01-09
DMF Number : 26778
Submission : 2013-01-07
Status : Active
Type : II
NDC Package Code : 67254-515
Start Marketing Date : 2014-03-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Ace Biopharm Co., Ltd.
Registration Date : 2021-11-04
Registration Number : Su289-10-ND
Manufacturer Name : Zhejiang Changhai Pharmaceuticals Co.,Ltd.
Manufacturer Address : 188 Mid Zhiyuan Avenue, Binhai New Area, Shaoxing City, Zhejiang Province, China
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-04-23
Pay. Date : 2012-11-23
DMF Number : 26604
Submission : 2012-12-21
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30592
Submission : 2016-05-26
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-11-28
Pay. Date : 2018-09-25
DMF Number : 33004
Submission : 2018-08-08
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-12-04
Pay. Date : 2015-09-30
DMF Number : 29760
Submission : 2015-11-12
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-03-25
Pay. Date : 2019-08-26
DMF Number : 33671
Submission : 2019-09-25
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-01-04
Pay. Date : 2017-09-20
DMF Number : 29859
Submission : 2015-09-17
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29137
Submission : 2015-02-27
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-02-21
Pay. Date : 2013-07-03
DMF Number : 22923
Submission : 2009-06-15
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-19
Pay. Date : 2013-06-25
DMF Number : 27179
Submission : 2013-07-16
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-11-28
Pay. Date : 2018-09-25
DMF Number : 33004
Submission : 2018-08-08
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30592
Submission : 2016-05-26
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-04-23
Pay. Date : 2012-11-23
DMF Number : 26604
Submission : 2012-12-21
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24723
Submission : 2011-03-04
Status : Inactive
Type : II
Comhony Biotech manufactures fermentation & semi-synthetic APIs which aim at dermatology, anti-biotics; mitochondria & memory health.
About the Company : Comhony Biotech is dedicated to supplying APIs and nutraceutical ingredients to worldwide clients in the pharmaceutical and nutraceutical sectors. Leveraging its proprietary techno...
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
About the Company : Headquartered in Fengxian District, Shanghai Minbiotech Co., Ltd. is a company specializing in the R&D and production of advanced pharmaceutical intermediates and biological API...
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
About the Company : Established in 1982, ChemWerth is a US-headquartered full-service generic active pharmaceutical ingredient (API) development and supply company. ChemWerth offers cGMP-quality APIs ...
About the Company : EUROAPI is the market leader in small molecule APIs with projected sales of about €1 billion in 2022. With around 200 APIs, it has one of the largest portfolios in the market. Th...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
About the Company : Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quali...
About the Company : Hubei Hongzhong Pharmaceutical Co., Ltd. was founded in 2007 and is located in Li Shizhen Pharmaceutical Industrial Park, Qichun County, Hubei Province. The company's products have...
About the Company : Established in 2010, Mac-Chem is a NMM Group company. Mac-Chem is focused on oncology and other niche specialty APIs. It supplies quality APIs to the top 15 oncology players in Ind...
About the Company : We produce Active Pharmaceutical Ingredients (APIs) providing integrated full-service capabilities. Olon’s ability to develop and manufacture Active Pharmaceutical Ingredients (...
About the Company : Synthland is an integrated pharmaceutical company that develops, produce and supplies Active Pharmaceutical Ingredients (APIs) and Intermediates. We also represent some well-known...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Reply
12 Jun 2024
Reply
20 Mar 2023
Reply
25 Aug 2022
Reply
03 Dec 2021
Reply
23 Mar 2021
Reply
13 Mar 2021
Reply
17 Oct 2020
Reply
20 Jul 2020
Reply
17 Jun 2020
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?